← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 9, 2020Last known activity
Dec 31, 2025
Timeline
2010s
- Jan 1, 2018
Climb Bio, Inc.— Founded
2020s
- Nov 1, 2024
Tenet Medicines— Acquired
Drugs by trial phase (3 distinct, 8 trials)
Phase 2 (1 own, 1 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (9)
- NCT07248865Lead sponsorPhase 1Dec 31, 2025
- NCT07096843Lead sponsorPhase 2Aug 25, 2025
- NCT07090655Lead sponsorEarly Phase 1Aug 11, 2025
- NCT07011043Lead sponsorPhase 1Jul 10, 2025
- NCT07011043OfficialPhase 1Jul 10, 2025
- NCT07043946OfficialPhase 1/Phase 2Jun 30, 2025
- NCT07043946Lead sponsorPhase 1/Phase 2Jun 30, 2025
- NCT04778592Lead sponsorPhase 2Feb 5, 2021
- NCT04688671Lead sponsorPhase 2Nov 9, 2020
Details
- Founded
- Wellesley, MA, US Jan 1, 2018
- Last known activity
- Dec 31, 2025